Lipoprotein-Associated Phospholipase A2, a Novel Cardiovascular Inflammatory Marker, in HIV-Infected Patients | Zendy

Alexandra Mangili | Zendy; Rameez Ahmad | Zendy; R L Wolfert | Zendy; Jeffrey T. Kuvin | Zendy; Joseph F. Polak | Zendy; Radosław Karaś | Zendy; C. A. Wanke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipoprotein-Associated Phospholipase A2, a Novel Cardiovascular Inflammatory Marker, in HIV-Infected Patients

Author(s) -

Alexandra Mangili,

Rameez Ahmad,

R L Wolfert,

Jeffrey T. Kuvin,

Joseph F. Polak,

Radosław Karaś,

C. A. Wanke

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit815

Subject(s) - medicine , lipoprotein associated phospholipase a2 , human immunodeficiency virus (hiv) , lipoprotein , immunology , inflammation , cholesterol

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an emerging biomarker of cardiovascular disease. This study was conducted to describe the distribution of Lp-PLA2 in a cohort of human immunodeficiency virus (HIV)-infected adults and to determine associations between Lp-PLA2, cardiometabolic risk factors, and subclinical atherosclerosis in this population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research